Oramed Pharmaceuticals Inc. (ORMP) vs Protara Therapeutics, Inc. (TARA)

Oramed Pharmaceuticals Inc. and Protara Therapeutics, Inc. are both Biotechnology companies. Oramed Pharmaceuticals Inc. and Protara Therapeutics, Inc. are of similar size ($199.3M and $198.0M). Protara Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Oramed Pharmaceuticals Inc. trades at 1.1×. Across the 10 metrics below, Oramed Pharmaceuticals Inc. leads on 8 and Protara Therapeutics, Inc. on 2.

Valuation

Metric ORMP TARA Biotechnology median
P/E 1.12 n/m 7.88
P/S 48.28 n/m 11.47
P/B 0.61 1.24 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 35.69 n/m 10.73
Earnings yield 89.43% (41.16%) (28.84%)
Free cash flow yield (2.69%) (33.24%) (23.03%)

Profitability

Metric ORMP TARA Biotechnology median
Gross margin 32.31% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 73.90% (45.80%) (57.72%)
Return on assets 65.52% (42.05%) (49.22%)
Return on invested capital (3.40%) (255.06%) 0.00%

Growth

Metric ORMP TARA Biotechnology median
Revenue growth (TTM) 347.77% — 5.64%
EPS growth (last fiscal year) 412.50% 38.25% —
Revenue growth, 5-year CAGR (5.85%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ORMP TARA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.98 10.97 4.73
Net debt to EBITDA 8.41 2.38 0.96

Dividend

Metric ORMP TARA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ORMP TARA Biotechnology median
Market cap 199.25m 197.97m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack